NIH corrects untruthful assertions by NIH Director Collins and NIAID Director Fauci that NIH had not funded gain-of-function research in Wuhan.

NIH corrects untruthful assertions by NIH Director Collins and NIAID Director Fauci that NIH had not funded gain-of-function research in Wuhan.

NIH states that EcoHealth Alliance violated Terms and Conditions of NIH grant AI110964

The NIH received the relevant documents in 2018 and reviewed the documents in 2020 and again in 2021.

The NIH--specifically, Collins, Fauci, and Tabak--lied to Congress, lied to the press, and lied to the public. Knowingly. Willfully. Brazenly.

Violation 1:

"No funds are provided and no funds can be used to support gain-of-function research covered under the October 17, 2014 White House Announcement (NIH Guide Notice NOT-OD-15-011)."

Violation 2:

"[S]hould any of the MERS-like or SARS-like chimeras generated under this grant show evidence of enhanced virus growth greater than 1 log over the parental backbone strain you must stop all experiments with

these viruses"

Violation 3:

"[S]hould any of the MERS-like or SARS-like chimeras generated under this grant show evidence of enhanced virus growth greater than 1 log over the parental backbone strain you must provide NIAID Program Officer and Grants Management Specialist with data"

Violation 4:

'Progress reports document grantee recipient accomplishments and compliance with terms of award. Progress reports...are due the 15th of the month preceding the month in which the budget period ends" (e.g., if the budget period ends 11/30, the due date is 10/15)."

Violation 5:

"Effective February 9, 2017, if the recipient organization has submitted a renewal application on or before the date by which a Final-RPPR would be required for the current competitive segment, then submission of an 'Interim-RPPR' via eRA Commons is now required."

Violation 6:

"NIAID defines a Highly Pathogenic Agent as an infectious Agent or Toxin that may warrant a

biocontainment safety level of BSL3 or higher When submitting future Progress Reports indicate at the beginning of the report If your IBC or equivalent body or official has determined, for example, by conducting a risk assessment, that the work being planned or performed under this grant may be conducted at a safety level that is lower than BSL3."

Violation 7:

"When submitting future Progress Reports indicate at the beginning of the report:

..

Any changes in the use of the Agent(s)..including its restricted experiments that have resulted in a change in the required biocontainment level, and any change in location"

Violation 8:

"When submitting future Progress Reports indicate at the beginning of the report:

..

If work with a new or additional Agent(s)..is proposed in the upcoming project period, provide list of the new and/or additional Agent(s) that will be studied"

https://twitter.com/R_H_Ebright/status/1450947395508858880